FKBP12 is a predictive biomarker for efficacy of anthracycline-based chemotherapy in breast cancer
2019 · Cancer Chemotherapy and Pharmacology · 24 citations
https://doi.org/10.1007/s00280-019-03923-1
Y
Yu Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
99
Papers
728
Citations
16
h-index
27
i10-index
Yu Wang is an academic researcher from Shanxi Medical University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Gastric Cancer Management and Outcomes. The author has an h-index of 16, co-authored 85 publications.
ORCID: 0000-0001-7706-2160Papers by this author
worksThe survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy
2014 · Radiation Oncology · 18 citations
https://doi.org/10.1186/s13014-014-0290-7
Complexin regulation of synaptic vesicle release: mechanisms in the central nervous system and specialized retinal ribbon synapses
2024 · Cell Communication and Signaling · 4 citations
https://doi.org/10.1186/s12964-024-01942-x
AhR-mediated histone lactylation drives cellular senescence during benzo[a]pyrene-evoked chronic obstructive pulmonary disease
2025 · Journal of Hazardous Materials · 4 citations
https://doi.org/10.1016/j.jhazmat.2025.139083
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat